Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genea Biomedx is a global leader in in vitro fertilisation (IVF) technologies, offering commercialized products such as benchtop embryo incubators with continuous monitoring, electronic sample traceability systems, workflow management software, embryo culture media suites, genetic analysis solutions for preimplantation genetic testing, semen analyzers, and advanced cryostorage systems. Their products are widely adopted by fertility clinics worldwide to improve clinical outcomes by reducing human error and optimizing laboratory workflows. The company does not develop therapeutic drugs but provides enabling technologies that support assisted reproductive procedures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genea Biomedx.